2531 Results (Page 98 of 102)
Healthcare Services Markets Research Reports
Malaysia Financial Assistance Programs Market Analysis
The Malaysia Financial Assistance Programs Market was valued at $45.6 Mn in 2023 and is projected to grow at a CAGR of 14.8% from 2023 to 2023, to $119.7 Mn by 2030. The market is driven by various sector such as rising drug cost, complex insurance landscape, regulatory environment, market competition, patient adherence concern etc. The prominent pharmaceutical companies providing financial assistance to patient are such as Abbott, AstraZeneca, Johnson & Johnson, Novartis among others.
Singapore Financial Assistance Programs Market Analysis
The Singapore Financial Assistance Programs Market was valued at $34 Mn in 2023 and is projected to grow at a CAGR of 15.2% from 2023 to 2023, to $91.6 Mn by 2030. The market is driven by various sector such as rising drug cost, complex insurance landscape, regulatory environment, market competition, patient adherence concern etc. The prominent pharmaceutical companies providing financial assistance to patient are such as Abbott, AstraZeneca, GSK among others.
Philippines Financial Assistance Programs Market Analysis
The Philippines Financial Assistance Programs Market was valued at $62.3 Mn in 2023 and is projected to grow at a CAGR of 15.1% from 2023 to 2023, to $166.9 Mn by 2030. The market is driven by various sector such as rising drug cost, complex insurance landscape, regulatory environment, market competition, patient adherence concern etc. The prominent pharmaceutical companies providing financial assistance to patient are such as Sanofi, Pfizer, GSK, among others.
Vietnam Financial Assistance Programs Market Analysis
The Vietnam Financial Assistance Programs Market was valued at $141.7 Mn in 2023 and is projected to grow at a CAGR of 14.83% from 2023 to 2023, to $373 Mn by 2030. The market is driven by various sector such as rising drug cost, complex insurance landscape, regulatory environment, market competition, patient adherence concern etc. The prominent pharmaceutical companies providing financial assistance to patient are such as Merck, GSK, Johnson & Johnson, Novartis among others.
Egypt Financial Assistance Programs Market Analysis
The Egypt Financial Assistance Programs Market was valued at $79.3 Mn in 2023 and is projected to grow at a CAGR of 16.1% from 2023 to 2023, to $225.6 Mn by 2030. The market is driven by various sector such as rising drug cost, complex insurance landscape, regulatory environment, market competition, patient adherence concern etc. The prominent pharmaceutical companies providing financial assistance to patient are such as Roche, Pfizer, Bayer, Merck, GSK, Johnson & Johnson, Novartis among others.
Kenya Financial Assistance Programs Market Analysis
The Kenya Financial Assistance Programs Market was valued at $19.8 Mn in 2023 and is projected to grow at a CAGR of 15.7% from 2023 to 2023, to $55.1 Mn by 2030. The market is driven by various sector such as rising drug cost, complex insurance landscape, regulatory environment, market competition, patient adherence concern etc. The prominent pharmaceutical companies providing financial assistance to patient are such as Abbott, AstraZeneca, AbbVie, Merck, GSK, Johnson & Johnson, Novartis among others.
Canada Radiology Service Market Analysis
The Canada Radiology Service Market was valued at $320 Mn in 2023 and is predicted to grow at a CAGR of 14.7% from 2023 to 2030, to $835.8 Mn by 2030. The key drivers of the market include increasing burden of chronic diseases, aging population, and technological advancements. The prominent players of the Canada Radiology Service Market are The Ottawa Hospital, Vancouver General Hospital, St. Paul’s Hospital, Royal Alexandra Hospital, Foothills Medical Centre, and McGill University Health Centre, among others.
South Africa Financial Assistance Programs Market Analysis
The South Africa Financial Assistance Programs Market was valued at $184.2 Mn in 2023 and is projected to grow at a CAGR of 15.83% from 2023 to 2023, to $444.9 Mn by 2030. The market is driven by various sector such as rising drug cost, complex insurance landscape, regulatory environment, market competition, patient adherence concern etc. The prominent pharmaceutical companies providing financial assistance to patient are such as Merck, GSK, Johnson & Johnson, Novartis among others.
US Radiology Service Market Analysis
The US Radiology Service Market was valued at $1,680 Mn in 2023 and is predicted to grow at a CAGR of 12.7% from 2023 to 2030, to $3,879.5 Mn by 2030. The key drivers of the market include increasing burden of chronic diseases, geriatric population, and technological advancements. The prominent players of the US Radiology Service Market are Massachusetts General Hospital, Brigham and Women’s Hospital, University of Pittsburgh Medical Centre, John Hopkins Hospital, UCLA-Health Ronald Reagan Medical Centre, and Stanford Healthcare, among others.
India Financial Assistance Programs Market Analysis
The India Financial Assistance Programs Market was valued at $515.4 Mn in 2023 and is projected to grow at a CAGR of 17.6% from 2023 to 2023, to $1,603.2 Mn by 2030. The market is driven by various sector such as rising drug cost, complex insurance landscape, regulatory environment, market competition, patient adherence concern etc. The prominent pharmaceutical companies providing financial assistance to patient are such as Cipla, Dr Reddy’s, Sanofi, Merck, GSK, Johnson & Johnson, Novartis among others.
Saudi Arabia Radiology Service Market Analysis
The Saudi Arabia Radiology Service Market was valued at $68 Mn in 2023 and is predicted to grow at a CAGR of 16.2% from 2023 to 2030, to $194.5 Mn by 2030. The key drivers of the market include increasing burden of chronic diseases, aging population, and growing awareness. The prominent players of the Saudi Arabia Radiology Service Market are Manipal Hospitals Radiology Group, Al Adwani General Hospital, Almana General Hospital, Dr. Sulaiman Al Habib Hospital, and Al Ahsa Hospital, among others.
UAE Radiology Service Market Analysis
The UAE Radiology Service Market was valued at $20 Mn in 2023 and is predicted to grow at a CAGR of 15.7% from 2023 to 2030, to $55.5 Mn by 2030. The key drivers of the market include increasing burden of chronic diseases, aging population, and growing awareness. The prominent players of the UAE Radiology Service Market are NMC Specialty Hospital, Zulekha Hospital, Al Zahra Hospital, Burjeel Medical City, Aster Hospital, and Prime Hospital, among others.
Brazil Radiology Service Market Analysis
The Brazil Radiology Service Market was valued at $100 Mn in 2023 and is predicted to grow at a CAGR of 15.7% from 2023 to 2030, to $277.6 Mn by 2030. The key drivers of the market include increasing burden of chronic diseases, aging population, and technological advancements. The prominent players of the Brazil Radiology Service Market are Samaritano, Sirio Libanes, Hospital Mae de Deus, Hospital Saude da Mulher, Hospital Naval Marcilio Dias, Hospital das Clínicas da Unicamp de Campinas, among others.
Mexico Radiology Service Market Analysis
The Mexico Radiology Service Market was valued at $60 Mn in 2023 and is predicted to grow at a CAGR of 14.95% from 2023 to 2030, to $159.1 Mn by 2030. The key drivers of the market include increasing burden of cancer, aging population, and emphasis on preventative care. The prominent players of the Mexico Radiology Service Market are Hospital Guadalajara, Hospital Angeles, Hospital Americano, Hospiten International Hospital Group, and Médica Sur, among others.
France Radiology Service Market Analysis
The France Radiology Service Market was valued at $110 Mn in 2023 and is predicted to grow at a CAGR of 13.7% from 2023 to 2030, to $270.2 Mn by 2030. The key drivers of the market include increasing burden of chronic diseases, rising demand for non-invasive procedures, and technological advancements. The prominent players of the France Radiology Service Market are Centre Chirugical Ambroise-Pare, CHP Saint-Gregoire, Chinique de L’Alma, Centre De Radiologie Croisette, Hospital Saint Louis, and La Clinique de l'Infirmerie Protestante, among others.
Canada Biobanks Market Analysis
The Canada Biobanks Market was valued at $6,139.20 Mn in 2023 and is predicted to grow at a CAGR of 8.80% from 2023 to 2030, to $11,079.34 Mn by 2030. The key drivers of this industry include the growing prevalence of chronic disease, government support and funding, and advancements in medical research. The industry is primarily dominated by players such as Thermo Fisher Scientific, Merck KGaA, QIAGEN, and Lonza among others.
Germany Radiology Service Market Analysis
The Germany Radiology Service Market was valued at $146.4 Mn in 2023 and is predicted to grow at a CAGR of 12.9% from 2023 to 2030, to $342.3 Mn by 2030. The key drivers of the market include increasing burden of chronic diseases, aging population, and technological advancements. The prominent players of the Germany Radiology Service Market are Clinic Passautraces, Helios Amper Hospital, Mittelbaden Clinic, Starnbergof Clinic, University Hospital Rechts der Isar, and University Hospital of Munich (LMU), among others.
US Biobanks Market Analysis
The US Biobanks Market was valued at $32,230.80 Mn in 2023 and is predicted to grow at a CAGR of 6.80% from 2023 to 2030, to $51,082.23 Mn by 2030. The key drivers of this industry include government initiatives, growing demand for human samples, and the prevalence of chronic diseases. The industry is primarily dominated by players such as Thermo Fisher Scientific, Merck KGaA, QIAGEN, and Tecan Group among others.
Spain Radiology Service Market Analysis
The Spain Radiology Service Market was valued at $77.2 Mn in 2023 and is predicted to grow at a CAGR of 13.7% from 2023 to 2030, to $189.6 Mn by 2030. The key drivers of the market include increasing burden of chronic diseases, rising demand for non-invasive procedures, and aging population. The prominent players of the Spain Radiology Service Market are Centro Medico Teknon, Hospital Universitari Sagrat Cor, University Clinic of Navarra, Quirónsalud Marbella Hospital, HM Monteprincipe, and Hospital General de Catalunya, among others.
Saudi Arabia Biobanks Market Analysis
The Saudi Arabia Biobanks Market was valued at $1,304.60 Mn in 2023 and is predicted to grow at a CAGR of 10.30% from 2023 to 2030, to $2,591.20 Mn by 2030. The key drivers of this industry include advancements in research, chronic disease prevalence, and government support. The industry is primarily dominated by players such as Thermo Fisher Scientific, Merck KGaA, QIAGEN, and Tecan Group among others.
UK Radiology Service Market Analysis
The UK Radiology Service Market was valued at $104 Mn in 2023 and is predicted to grow at a CAGR of 12.7% from 2023 to 2030, to $240.2 Mn by 2030. The key drivers of the market include increasing burden of chronic diseases, rising demand for non-invasive procedures, and technological advancements. The prominent players of the UK Radiology Service Market are Chelsea and Westminister Hospital, St. Mary’s Hospital, St. George’s Hospital, The Royal London Hospital, Hammersmith Hospital, and Guy’s and St. Thomas’ Hospitals, among others.
UAE Biobanks Market Analysis
The UAE Biobanks Market was valued at $383.70 Mn in 2023 and is predicted to grow at a CAGR of 9.80% from 2023 to 2030, to $738.26 Mn by 2030. The key drivers of this industry include personalized medicine, increasing biomedical research, and the rising prevalence of chronic disease. The industry is primarily dominated by players such as Thermo Fisher Scientific, Merck KGaA, QIAGEN, and Tecan Group among others.
China Radiology Service Market Analysis
The China Radiology Service Market was valued at $321.6 Mn in 2023 and is predicted to grow at a CAGR of 16.2% from 2023 to 2030, to $919.8 Mn by 2030. The key drivers of the market include increasing burden of chronic diseases, aging population, and technological advancements. The prominent players of the China Radiology Service Market are Peking Union Medical College Hospital, Shanghai Huashan Hospital, Guangzhou Medical University Affiliated Cancer Hospital, Fudan University Shanghai Cancer Centre, Beijing Cancer Hospital, and Shanghai Renji Hospital, among others.
China Biobanks Market Analysis
The China Biobanks Market was valued at $6,168.90 Mn in 2023 and is predicted to grow at a CAGR of 10.30% from 2023 to 2030, to $12,252.90 Mn by 2030. The key drivers of this industry include government support, rising chronic diseases, and research and development initiatives. The industry is primarily dominated by players such as Thermo Fisher Scientific, Merck KGaA, QIAGEN, and Tecan Group among others.
Indonesia Radiology Service Market Analysis
The Indonesia Radiology Service Market was valued at $24 Mn in 2023 and is predicted to grow at a CAGR of 14.7% from 2023 to 2030, to $62.7 Mn by 2030. The key drivers of the market include increasing burden of chronic diseases, aging population, and healthcare infrastructure development. The prominent players of the Indonesia Radiology Service Market are Rumah Sakit Cipto Mangunkusumo (RSCM), Rumah Sakit Pondok Indah, Rumah Sakit Siloam, Rumah Sakit Mitra Keluarga, and Rumah Sakit Pusat Pertamina (RSPP), among others.
